Gilbert Sharpe - Modern Mobility Ex Advisor
MDRM Stock | USD 0 0.00 0.00% |
Executive
Mr. Gilbert Sharpe is Director of the Company. Mr. Sharpe was the former longtime director of the Legal Branch of the Ontario Ministry of Health and LongTerm Care and brings invaluable experience from a distinguished 40year career in legal practice and advisory roles. Currently, Mr. Sharpe operates a boutique healthcare advisory service following fifteen years in private practice as a partner at several major Bay Street, Ontario law firms. Mr. Sharpe offers unparalleled experience in healthcare public policy and regulation, and intimately understands the complex realm of evolving public and private healthcare in Canada. Through his involvement with the Ministry of Health since 1975, and associated work with numerous government ministries and agencies, Mr. Sharpe has influenced some of the most important legal issues and policy matters affecting modern health care. This includes the development of legislation and policies to improve the Ontario and Canadian health care system. This context is invaluable for those who seek to impact change in healthcare. Internationally, Mr. Sharpe was an advisor on healthcare projects for the World Bank, InterAmerican Bank, and the World Health Organization. He advised on US healthcare reforms in part during his tenure as a professor in the health law group at Loyola University in Chicago. Mr. Sharpe holds several professorships, including at the Faculty of Law and the Institute of Health Policy, Management and Evaluation at the University of Toronto. Mr. Sharpe received his LLB and LLM from Osgoode Hall Law School. He is also editorinchief of health law in Canada and the former president of the Canadian Institute of Law and Medicine. He has published several books, hundreds of articles, and is a soughtafter speaker at conferences. since 2017.
Tenure | 7 years |
Phone | 416-254-2581 |
Web | https://galileolife.com |
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Damian David | Healthcare Triangle | N/A | |
Anand Kumar | Healthcare Triangle | 50 | |
Paul Reuscher | Forian Inc | N/A | |
Timothy Cruickshank | Heartbeam | 43 | |
Richa Gujarati | Heartbeam | N/A | |
Rebecca Adams | Forian Inc | N/A | |
Amanda Hammer | Mangoceuticals, Common Stock | 38 | |
Yew CPA | EUDA Health Holdings | 56 | |
Scott Fenstermacher | HealthStream | 55 | |
Martin FCA | FOXO Technologies | 67 | |
RN BSN | HealthStream | 48 | |
Christophe Louvion | National Research Corp | 51 | |
Vinitha Ramnathan | National Research Corp | N/A | |
Michael Campana | Healthcare Triangle | N/A | |
Michael McQuigg | HealthStream | 56 | |
Kevin OHara | HealthStream | 54 | |
Linda Stacy | National Research Corp | N/A | |
Arthur Newman | HealthStream | 75 | |
Jennifer Baron | National Research Corp | N/A | |
Andy Monnich | National Research Corp | 48 | |
Kenneth Persen | Heartbeam | N/A |
Modern Mobility Aids Leadership Team
Elected by the shareholders, the Modern Mobility's board of directors comprises two types of representatives: Modern Mobility inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Modern. The board's role is to monitor Modern Mobility's management team and ensure that shareholders' interests are well served. Modern Mobility's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Modern Mobility's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tito DiMarco, President CEO, Director | ||
Gilbert Sharpe, Ex Advisor |
Modern Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Modern Mobility a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 3.02 M | |||
Shares Outstanding | 127.55 M | |||
Price To Earning | (2.08) X | |||
Net Income | (248.24 K) | |||
Cash And Equivalents | 1.41 K | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (291.89 K) | |||
Earnings Per Share | (0.02) X | |||
Beta | 0.5 | |||
Market Capitalization | 2.93 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Modern Pink Sheet
Modern Mobility financial ratios help investors to determine whether Modern Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Modern with respect to the benefits of owning Modern Mobility security.